Literature DB >> 10806458

Clinical utility of the Trail Making Test practice time.

M D Thompson1, J G Scott, S W Dickson, J D Schoenfeld, W D Ruwe, R L Adams.   

Abstract

The Trail Making Test (TMT) is one of the most frequently used measures in clinical neuropsychology. Data obtained from the TMT practice times were analyzed to determine their utility in predicting success and failure on the full version of the test and to allow establishment of criteria by which to judge administration or discontinuation of the full test. Results indicated that TMT practice times were useful in predicting successful completion of Part A and B of the TMT. Tables are provided which describe the classification accuracy of various TMT practice times. These tables allow clinicians to select a practice-time cutoff and then use the cutoff as a heuristic to assist in the decision to administer the remainder of that particular part of the TMT or discontinue the test. A 20-s cutoff resulted in optimal prediction of successful completion (< 180 s) of TMT Part A. A cutoff of 30 s optimally predicted successful completion (< 300 s) of TMT Part B.

Entities:  

Mesh:

Year:  1999        PMID: 10806458     DOI: 10.1076/1385-4046(199911)13:04;1-Y;FT450

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  5 in total

1.  Neuropsychological Performance in Autoimmune Limbic Encephalitis: Evidence from an Immunotherapy-Naïve Cohort.

Authors:  Christoph Mueller; Lisa Langenbruch; Johanna M H Rau; Tobias Brix; Christine Strippel; Andre Dik; Kristin S Golombeck; Constanze Mönig; Andreas Johnen; Saskia Räuber; Heinz Wiendl; Sven G Meuth; Jens Bölte; Stjepana Kovac; Nico Melzer
Journal:  Arch Clin Neuropsychol       Date:  2022-05-16       Impact factor: 3.448

2.  The cyclical lower extremity exercise for Parkinson's trial (CYCLE): methodology for a randomized controlled trial.

Authors:  Anson B Rosenfeldt; Matthew Rasanow; Amanda L Penko; Erik B Beall; Jay L Alberts
Journal:  BMC Neurol       Date:  2015-04-24       Impact factor: 2.474

3.  Influencing factors on instrumental activities of daily living functioning in people with mild cognitive disorder - a secondary investigation of cross-sectional data.

Authors:  Marina Bruderer-Hofstetter; Ellen Gorus; Elise Cornelis; André Meichtry; Patricia De Vriendt
Journal:  BMC Geriatr       Date:  2022-10-11       Impact factor: 4.070

4.  Hypertension and cognitive decline: impact on executive function.

Authors:  Augusto Vicario; Carlos D Martinez; Dolores Baretto; Alejandra Diaz Casale; Liliana Nicolosi
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-10       Impact factor: 3.738

5.  Polymorphism in the LASP1 gene promoter region alters cognitive functions of patients with schizophrenia.

Authors:  Chieh-Hsin Lin; Sheng Yang; Yu-Jhen Huang; Hsien-Yuan Lane
Journal:  Sci Rep       Date:  2019-12-11       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.